Outcome measures assisting treatment optimization in multiple sclerosis

Objective To review instruments used to assess disease stability or progression in persons with multiple sclerosis (pwMS) that can guide clinicians in optimizing therapy. Methods A non-systematic review of scientific literature was undertaken to explore modalities of monitoring symptoms and the disease evolution of MS. Results Multiple outcome measures, or tools, have been developed for use in MS research as well as for the clinical management of pwMS. Beginning with the Expanded Disability Status Scale, introduced in 1983, clinicians and researchers have developed monitoring modalities to assess all aspects of MS and the neurological impairment it causes. Conclusions Much progress has been made in recent decades for the management of MS and for the evaluation of disease progression. New technology, such as wearable sensors, will provide new opportunities to better understand changes in function, dexterity, and cognition. Essential work over the decades since EDSS was introduced continues to improve our ability to treat this debilitating disease.

Automated summary

Various instruments have been developed to assess disease stability or progression in individuals with multiple sclerosis, providing clinicians with valuable tools to optimize therapy. Technological advancements, such as wearable sensors, offer new opportunities to better understand changes in MS-related symptoms and impairment. Continued research and development have significantly improved the management and evaluation of MS in recent decades.